showed that ex vivo antigen-loaded monocytes elicit potent therapeutic anti-tumor T cell responses in mice by promoting efficient antigen transfer mediated by gap junction via connexin 43 between CD8a+ DCs and monocytes (127). The gene discussed is CD8A; the disease is neoplasm.